Cormorant Asset Management, LP Bluebird Bio, Inc. Call Options Transaction History
Cormorant Asset Management, LP
- $1.74 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BLUE
# of Institutions
173Shares Held
104MCall Options Held
827KPut Options Held
1.23M-
Black Rock Inc. New York, NY15.2MShares$14 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$9.66 Million0.0% of portfolio
-
Granahan Investment Management, LLC Waltham, MA7.71MShares$7.09 Million0.35% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN6.39MShares$5.88 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.24MShares$5.74 Million0.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $71M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...